George Renaudin II - 24 Feb 2023 Form 4 Insider Report for HUMANA INC (HUM)

Role
President, Medicare & Medicaid
Signature
George Renaudin II
Issuer symbol
HUM
Transactions as of
24 Feb 2023
Net transactions value
-$177,054
Form type
4
Filing time
28 Feb 2023, 11:38:01 UTC
Previous filing
08 Feb 2023
Next filing
23 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUM Humana Common Options Exercise $0 +1,393 $0.000000 1,393 24 Feb 2023 Direct F10
transaction HUM Humana Common Tax liability $177,054 -347 -25% $510.24 1,046 24 Feb 2023 Direct F11
holding HUM Humana Common 474 24 Feb 2023 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Options Award $0 +4,162 $0.000000 4,162 24 Feb 2023 Humana Common 4,162 $510.24 Direct F2
transaction HUM Restricted Stock Units Award $0 +1,078 $0.000000 1,078 24 Feb 2023 Humana Common 1,078 Direct F3, F8
holding HUM Restricted Stock Units 241 24 Feb 2023 Humana Common 241 Direct F3, F4
holding HUM Restricted Stock Units 1,241 24 Feb 2023 Humana Common 1,241 Direct F3, F5
holding HUM Restricted Stock Units 459 24 Feb 2023 Humana Common 459 Direct F3, F6
holding HUM Restricted Stock Units 609 24 Feb 2023 Humana Common 609 Direct F3, F7
holding HUM Phantom Stock Units 148 24 Feb 2023 Humana Common 148 See Footnote F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held for the benefit of reporting person as of January 31, 2023 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
F2 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F3 Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F4 Restricted stock units granted to reporting person on 2/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
F5 Restricted stock units granted to reporting person on 9/1/2021, 100% of the award is vesting on 9/1/2024.
F6 Restricted stock units granted to reporting person on 2/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F7 Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025.
F8 Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F9 Phantom Stock Units held for the benefit of reporting person as of January 31, 2023 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.
F10 Performance Stock Units vested on 2/24/23, not required to be reported until vest.
F11 Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23.